Recent Company News

• 06:30 PM ET Jul 29, 2026
  

  Immutep reports Q4 net cash from / (used in) operating activities (A$39.0M) - Appendix 4C (A$0.05, 0.00)

• 09:43 PM ET Jul 12, 2026
  

  StreetAccount Summary - Trading higher/lower: Australia & New Zealand midday

• 08:11 PM ET Jul 12, 2026
  

  Immutep issues update on INSIGHT-003 Phase I trial evaluating eftilagimod alfa (efti); ~92% of patients had no or low PD-L1 expression (pre-ASX open) (A$0.06, +0.01)

• 06:00 PM ET Jul 06, 2026
  

  Pomerantz LLP Reminds Investors with Losses on their Investment in Immutep Limited of Class Action Lawsuit - IMMP

• 02:31 PM ET Jul 06, 2026
  

  Immutep Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - IMMP

• 02:20 PM ET Jul 06, 2026
  

  IMMP Investors Have Opportunity to Lead Immutep Limited Securities Fraud Lawsuit with the Schall Law Firm

• 11:00 AM ET Jul 04, 2026
  

  Pomerantz LLP Posts Reminder: Legal Action Filed Against Immutep Limited - IMMP